Mechanisms of 5-hydroxytryptamine-induced inhibition in the porcine myometrium

Journal of Autonomic Pharmacology

Volumn 19, Issue 2, 1999, Pages 65-75

  Kitazawa, T ^a   Takaoka, K ^a   Taneike, T ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 4 AMINOPYRIDINE; APAMIN; BETA ESCIN; CAFFEINE; CARBACHOL; CHARYBDOTOXIN; CYCLIC AMP; EGTAZIC ACID; GLIBENCLAMIDE; IMIDAZOLE; ISOBUTYLMETHYLXANTHINE; MILRINONE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; SEROTONIN; TETRYLAMMONIUM; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; MUSCLE FORCE; NONHUMAN; TISSUE LEVEL; UTERUS CONTRACTION;

ANIMALS; CALCIUM; CYCLIC AMP; FEMALE; MYOMETRIUM; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; SEROTONIN; SEROTONIN ANTAGONISTS; SWINE; UTERINE CONTRACTION;

EID: 0032767614     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1999.00117.x     Document Type: Article

References (40)

1. 2+ and cyclic AMP signaling systems in smooth muscle. Cell Signal., 3, 371-385.
2. 2+ level and contraction in vascular smooth muscle. J. Pharmacol. Exp. Ther., 249, 895-900.
3. 2+ influx and contraction in vascular smooth muscle. Jpn. J. Pharmacol., 59, 263-265.
4. BEAVO, J.A. & REIFSNYDER, D.H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci., 11, 150-155.
5. BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
6. + channels by protein kinase A and phosphatase inhibitors. Am. J. Physiol., 261, G387-G392.
7. CARTER, D., CHAMPNEY, M., HWANG, B. & EGLEN, R.M. (1995). Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol., 280, 243-250.
8. CHASIN, M.L. & HARRIS, D.N. (1976). Inhibitors and activators of cyclic neucleotide phosphodiesterase. Adv. Cyclic Nucleotides Res., 7, 225-264.
9. COHEN, M.L. & WITTENAUER, L.A. (1987). Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle. J. Cardiovasc. Pharmacol., 10, 176-181.
10. HALL, I.P., DONALDSON, J. & HILL, S.J. (1989). Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle. Br. J. Pharmacol., 97, 603-613.
11. HINE, R.J., ORSINI, M.W. & HEGSTRAND, R. (1985). Changes in tissue histamine during the estrous cycle, pregnancy and pseudopregnancy in the golden hamster. Proc. Soc. Exp. Biol. Med., 179, 271-278.
12. HIRST, W.D., PRICE, G.W., RATTRAY, M. & WILKIN, G.P. (1997). Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in the rat cultured astrocytes. Br. J. Pharmacol., 120, 509-515.
13. 2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms. Br. J. Pharmacol., 117, 419-426.
14. HORIUTI, K. (1988). Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibers. J. Physiol., 398, 131-148.
15. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
16. HZUKA, K., IKEBE, M., SOMLYO, A.V. & SOMLYO, A.P. (1994). Introduction of high molecular weight (IgG) proteins into receptor coupled, permeabilized smooth muscle. Cell Calcium, 16, 431-445.
17. KARAKI, H., OZAKI, H., HORI, M., MITUI-SAITO, M., AMANO, K., HARADA, K., MIYAMOTO, S., NAKAZAWA, H., KWON, S.C. & SATO, K. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev., 49, 157-230.
18. 7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine. Br. J. Pharmacol. 123, 173-182.
19. KITAZAWA, T., SHISHIDO, H., SATO, T. & TANEIKE, T. (1997). Histamine mediates the muscle layer-specific responses in the isolated swine myometrium. J. Vet. Pharmacol. Therap., 20, 187-197.
20. KONISHI, M., OLSON, A., HOLLINGWORTH, S. & BAYLOR, S.M. (1988). Myoplasmic binding of fura-2 investigated by steady-state fluorescence and absorbance measurements. Biophys. J., 53, 1089-1104.
21. 7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol., 117, 926-930.
22. 7 receptors? Br. J. Pharmacol., 114, 383P.
23. MARTINEZ-MIR, M.I., ESTAN, L., MORALES OLIVAS, F.J. & RUBIO, E. (1992). Effect of histamine and histamine analogues on human isolated myometrial strips. Br. J. Pharmacol., 107, 528-531.
24. MCDONALD, L.E. (1975). Female reproductive system. In: Veterinary Endocrinology and Reproduction, 2nd edn., pp. 247-303. Philadelphia, PA: Lea and Febiger.
25. NISHIMURA, I. & VAN BREEMEN, C. (1989). Direct regulation of smooth muscle contractile elements by second messenger. Biochem. Biophys. Res. Commun., 163, 929-935.
26. NORMAN, J. (1996). Nitric oxide and the myometrium. Pharmacol. Ther., 70, 91-100.
27. OZAKI, H., SATO, K., SATOH, T. & KARAKI, H. (1987). Simultaneous recordings of calcium signals and mechanical activity using fluorescent dye fura 2 in isolated strips of vascular smooth muscle. Jpn. J. Pharmacol., 45, 429-433.
28. OZAKI, H., BLONDFIELD, D.P., HORI, M., SANDERS, K.M. & PUBLICOVER, N.G. (1992). Cyclic AMP-mediated regulation of excitation-contraction coupling in canine gastric smooth muscle. J. Physiol., 447, 351-372.
29. 2+ and contraction induced by various stimulants and relaxants in canine tracheal smooth muscle. Pflugers Arch., 416, 351-359.
30. PADILLA, L., REINICKE, K., MONTESINO, H., VILLENA, F., ASENCIO, H., CRUZ, M. & RUDOLPH, M.I. (1990). Histamine content and mast cells distribution in mouse uterus: the effect of sexual hormones, gestation and labor. Cell. Mol. Biol., 36, 93-100.
31. PLASSAT, J.-L., AMLAIKY, N. &. HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229-236.
32. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 8547-8551.
33. RUDOLPH, M.I., REINICKE, K., CRUZ, M.A., GALLARDO, V., GONZALEZ, C. & BARDISA, L. (1993). Distribution of mast cells and the effect of their mediators on contractility in human myometrium. Br. J. Obst. Gynecol., 100, 1125-1130.
34. SANDERS, K.M. & WARD, S.M. (1992). Nitric oxide as a mediator of non-adrenergic non-cholinergic neurotransmission. Am. J. Physiol., 262, G379-G392.
35. 2+ from intracellular stores. Br. J. Pharmacol., 99, 261-266.
36. 7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol., 117, 993-994.
37. TANEIKE, T., KITAZAWA, T., FUNAKURA, H., ASANUMA, K., TUJI, S., YAMADA, M., TERAOKA, H. & OHGA, A. (1999). Smooth muscle layer-specific variations in the autonomic innervation of the bovine myometrium. Gen. Pharmacol., 32, 91-100.
38. 7 receptor subtype. Br. J. Pharmacol., 118, 1421-1428.
39. VAN RIPER, D.A., WEAVER, B.A., STULL, J.T. & REMBOLD, C.M. (1995). Myosin light chain kinase phosphorylation in swine carotid artery contraction and relaxation. Am. J. Physiol., 268, H2466-H2475.
40. ++ release. J. Pharmacol. Exp. Ther., 275, 1077-1083.